商品簡介
Motivated by a belief that current approaches to drug research and development, marketing, and pricing do not address the needs of the hundreds of millions of people living in the developing world, Cohen (U. of Toronto, Canada), Illingworth (Northeastern U., US), and Schuklenk (co-editor, Bioethics) present 25 contributions that analyze the international structure of the pharmaceutical industry from legal, ethical, and policy perspectives. Topics addressed include profit as an improper incentive for just drug development, improper relations between physicians and the pharmaceutical industry, industry perspectives on corporate social responsibility, access to medications as an issue of social justice, moral and practical problems of advanced purchase commitments, patents and medication pricing and their implications for access and availability, research ethics, expanding access to generic pharmaceuticals, the impact of bilateral and regional free trade agreements on domestic intellectual property rules on pharmaceuticals, essential medicines and human rights, pharmaceutical cost-effectiveness pricing, and national responsibility in the provision of basic medicines. Distributed in the US by the U. of Michigan Press. Annotation c2007 Book News, Inc., Portland, OR (booknews.com)
作者簡介
Jillian Clare Cohen is an Assistant Professor at the Leslie Dan Faculty of Pharmacy, University of Toronto and Director of the Comparative Program on Health and Society. She conducts research and publishes widely on drug access including corruption and intellectual property rights. She has also advised governments and international organizations on pharmaceutical policy. Patricia Illingworth is an Associate Professor at Northeastern University. She has written three books, AIDS and the Good Society (1991), Trusting Medicine ( 2005), and Ethical Health Care (2006) with Wendy Parmet. Udo Schuklenk is a Professor of Ethics in Public Policy and Corporate Governance at Glasgow Caledonian University. He is a co-editor of the journal Bioethics and author of Access to Experimental Drugs in Terminal Illness: Ethical Issues (1998).
